{
    "info": {
        "nct_id": "NCT04351243",
        "official_title": "A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)",
        "inclusion_criteria": "1. Male or non-pregnant female age ≥18 years, inclusive\n2. Subject (or legally authorized representative) is able and willing to provide written informed consent, which includes compliance with study requirements and restrictions listed in the consent form\n3. Has laboratory-confirmed SARS-CoV-2 infection as determined by PCR or other approved clinical testing prior to randomization\n4. Radiographic evidence of bilateral infiltrates\n5. Subject requires high-flow oxygen or meets clinical classification for ARDS\n6. Elevated serum CRP or ferritin\n7. Subjects who have been treated with convalescent plasma (CP) prior to enrollment are eligible if the subject continues to meet all inclusion criteria at screening\n8. The use of investigational anti-viral treatment (e.g., remdesivir) is allowed if the subject continues to meet all inclusion criteria at screening\n\nAdditional inclusion criteria are detailed in the protocol\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "1. Evidence of life-threatening dysrhythmia or cardiac arrest on presentation\n2. Intubated >72 hours\n3. Absolute neutrophil count < 1,000 per mm3\n4. Platelet count < 50,000 per mm3\n5. AST or ALT > 5X upper limit of normal\n6. eGFR <30 mL/min/1.73m2 or requiring hemofiltration or dialysis\n7. History of known anti-GM-CSF autoantibodies or pulmonary alveolar proteinosis\n8. Severe chronic respiratory disease (e.g., COPD, PAH, IPF, ILD) requiring supplemental oxygen therapy or mechanical ventilation pre-hospitalization (e.g., prior to COVID-19 diagnosis)\n9. Use of any immunomodulatory biologic, cell therapy, or small molecule JAK inhibitor within past 7 days or 5 half lives or planned use of any of these agents unless approved by medical monitor\n10. Chronic (>4 weeks) use of corticosteroids >10mg/day of prednisone or equivalent\n11. Known or suspected active and untreated TB, HIV, hepatitis B or C infection\n\nAdditional exclusion criteria are detailed in the protocol.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "8. The use of investigational anti-viral treatment (e.g., remdesivir) is allowed if the subject continues to meet all inclusion criteria at screening",
            "criterions": [
                {
                    "exact_snippets": "use of investigational anti-viral treatment (e.g., remdesivir) is allowed if the subject continues to meet all inclusion criteria at screening",
                    "criterion": "use of investigational anti-viral treatment",
                    "requirements": [
                        {
                            "requirement_type": "allowed",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. Subject requires high-flow oxygen or meets clinical classification for ARDS",
            "criterions": [
                {
                    "exact_snippets": "Subject requires high-flow oxygen",
                    "criterion": "high-flow oxygen requirement",
                    "requirements": [
                        {
                            "requirement_type": "requirement",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "meets clinical classification for ARDS",
                    "criterion": "clinical classification for ARDS",
                    "requirements": [
                        {
                            "requirement_type": "meets classification",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Male or non-pregnant female age ≥18 years, inclusive",
            "criterions": [
                {
                    "exact_snippets": "Male or non-pregnant female",
                    "criterion": "sex and pregnancy status",
                    "requirements": [
                        {
                            "requirement_type": "sex or pregnancy status",
                            "expected_value": [
                                "male",
                                "non-pregnant female"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "age ≥18 years, inclusive",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "age",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "7. Subjects who have been treated with convalescent plasma (CP) prior to enrollment are eligible if the subject continues to meet all inclusion criteria at screening",
            "criterions": [
                {
                    "exact_snippets": "Subjects who have been treated with convalescent plasma (CP) prior to enrollment",
                    "criterion": "prior treatment with convalescent plasma",
                    "requirements": [
                        {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "if the subject continues to meet all inclusion criteria at screening",
                    "criterion": "all inclusion criteria at screening",
                    "requirements": [
                        {
                            "requirement_type": "meets criteria",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. Elevated serum CRP or ferritin",
            "criterions": [
                {
                    "exact_snippets": "Elevated serum CRP",
                    "criterion": "serum CRP",
                    "requirements": [
                        {
                            "requirement_type": "level",
                            "expected_value": "elevated"
                        }
                    ]
                },
                {
                    "exact_snippets": "Elevated ... ferritin",
                    "criterion": "serum ferritin",
                    "requirements": [
                        {
                            "requirement_type": "level",
                            "expected_value": "elevated"
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Radiographic evidence of bilateral infiltrates",
            "criterions": [
                {
                    "exact_snippets": "Radiographic evidence of bilateral infiltrates",
                    "criterion": "bilateral infiltrates",
                    "requirements": [
                        {
                            "requirement_type": "radiographic evidence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Subject (or legally authorized representative) is able and willing to provide written informed consent, which includes compliance with study requirements and restrictions listed in the consent form",
            "criterions": [
                {
                    "exact_snippets": "Subject (or legally authorized representative) is able and willing to provide written informed consent",
                    "criterion": "informed consent",
                    "requirements": [
                        {
                            "requirement_type": "ability to provide",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "willingness to provide",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "compliance with study requirements and restrictions listed in the consent form",
                    "criterion": "compliance with study requirements and restrictions",
                    "requirements": [
                        {
                            "requirement_type": "willingness to comply",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Has laboratory-confirmed SARS-CoV-2 infection as determined by PCR or other approved clinical testing prior to randomization",
            "criterions": [
                {
                    "exact_snippets": "Has laboratory-confirmed SARS-CoV-2 infection as determined by PCR or other approved clinical testing",
                    "criterion": "SARS-CoV-2 infection",
                    "requirements": [
                        {
                            "requirement_type": "confirmation method",
                            "expected_value": [
                                "PCR",
                                "other approved clinical testing"
                            ]
                        },
                        {
                            "requirement_type": "status",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "prior to randomization",
                    "criterion": "timing of SARS-CoV-2 infection confirmation",
                    "requirements": [
                        {
                            "requirement_type": "timing",
                            "expected_value": "prior to randomization"
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "7. History of known anti-GM-CSF autoantibodies or pulmonary alveolar proteinosis",
            "criterions": [
                {
                    "exact_snippets": "History of known anti-GM-CSF autoantibodies",
                    "criterion": "anti-GM-CSF autoantibodies",
                    "requirements": [
                        {
                            "requirement_type": "history of presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "History of ... pulmonary alveolar proteinosis",
                    "criterion": "pulmonary alveolar proteinosis",
                    "requirements": [
                        {
                            "requirement_type": "history of presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "1. Evidence of life-threatening dysrhythmia or cardiac arrest on presentation",
            "criterions": [
                {
                    "exact_snippets": "Evidence of life-threatening dysrhythmia",
                    "criterion": "life-threatening dysrhythmia",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "cardiac arrest on presentation",
                    "criterion": "cardiac arrest",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "3. Absolute neutrophil count < 1,000 per mm3",
            "criterions": [
                {
                    "exact_snippets": "Absolute neutrophil count < 1,000 per mm3",
                    "criterion": "absolute neutrophil count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 1000,
                                "unit": "per mm3"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "6. eGFR <30 mL/min/1.73m2 or requiring hemofiltration or dialysis",
            "criterions": [
                {
                    "exact_snippets": "eGFR <30 mL/min/1.73m2",
                    "criterion": "eGFR",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 30,
                                "unit": "mL/min/1.73m2"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "requiring hemofiltration",
                    "criterion": "hemofiltration",
                    "requirements": [
                        {
                            "requirement_type": "requirement",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "requiring ... dialysis",
                    "criterion": "dialysis",
                    "requirements": [
                        {
                            "requirement_type": "requirement",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "2. Intubated >72 hours",
            "criterions": [
                {
                    "exact_snippets": "Intubated >72 hours",
                    "criterion": "intubation duration",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">",
                                "value": 72,
                                "unit": "hours"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "4. Platelet count < 50,000 per mm3",
            "criterions": [
                {
                    "exact_snippets": "Platelet count < 50,000 per mm3",
                    "criterion": "platelet count",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<",
                                "value": 50000,
                                "unit": "per mm3"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "10. Chronic (>4 weeks) use of corticosteroids >10mg/day of prednisone or equivalent",
            "criterions": [
                {
                    "exact_snippets": "Chronic (>4 weeks) use of corticosteroids",
                    "criterion": "corticosteroid use",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">",
                                "value": 4,
                                "unit": "weeks"
                            }
                        },
                        {
                            "requirement_type": "chronicity",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "corticosteroids >10mg/day of prednisone or equivalent",
                    "criterion": "corticosteroid dosage",
                    "requirements": [
                        {
                            "requirement_type": "dosage",
                            "expected_value": {
                                "operator": ">",
                                "value": 10,
                                "unit": "mg/day of prednisone or equivalent"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "5. AST or ALT > 5X upper limit of normal",
            "criterions": [
                {
                    "exact_snippets": "AST or ALT > 5X upper limit of normal",
                    "criterion": "AST level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 5,
                                "unit": "X upper limit of normal"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "AST or ALT > 5X upper limit of normal",
                    "criterion": "ALT level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 5,
                                "unit": "X upper limit of normal"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "8. Severe chronic respiratory disease (e.g., COPD, PAH, IPF, ILD) requiring supplemental oxygen therapy or mechanical ventilation pre-hospitalization (e.g., prior to COVID-19 diagnosis)",
            "criterions": [
                {
                    "exact_snippets": "Severe chronic respiratory disease (e.g., COPD, PAH, IPF, ILD)",
                    "criterion": "severe chronic respiratory disease",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "requiring supplemental oxygen therapy",
                    "criterion": "supplemental oxygen therapy",
                    "requirements": [
                        {
                            "requirement_type": "requirement",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "requiring ... mechanical ventilation pre-hospitalization (e.g., prior to COVID-19 diagnosis)",
                    "criterion": "mechanical ventilation pre-hospitalization",
                    "requirements": [
                        {
                            "requirement_type": "requirement",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "9. Use of any immunomodulatory biologic, cell therapy, or small molecule JAK inhibitor within past 7 days or 5 half lives or planned use of any of these agents unless approved by medical monitor",
            "criterions": [
                {
                    "exact_snippets": "Use of any immunomodulatory biologic, cell therapy, or small molecule JAK inhibitor within past 7 days or 5 half lives",
                    "criterion": "use of immunomodulatory biologic, cell therapy, or small molecule JAK inhibitor",
                    "requirements": [
                        {
                            "requirement_type": "recency of use",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 7,
                                        "unit": "days"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 5,
                                        "unit": "half lives"
                                    }
                                ]
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "planned use of any of these agents unless approved by medical monitor",
                    "criterion": "planned use of immunomodulatory biologic, cell therapy, or small molecule JAK inhibitor",
                    "requirements": [
                        {
                            "requirement_type": "planned use",
                            "expected_value": false
                        },
                        {
                            "requirement_type": "exception",
                            "expected_value": "unless approved by medical monitor"
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "Additional inclusion criteria are detailed in the protocol",
            "criterions": []
        }
    ],
    "failed_exclusion": [
        {
            "line": "Additional exclusion criteria are detailed in the protocol.",
            "criterions": []
        },
        {
            "line": "11. Known or suspected active and untreated TB, HIV, hepatitis B or C infection",
            "criterions": [
                {
                    "exact_snippets": "Known or suspected active and untreated TB",
                    "criterion": "tuberculosis infection",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "active"
                        },
                        {
                            "requirement_type": "treatment_status",
                            "expected_value": "untreated"
                        }
                    ]
                },
                {
                    "exact_snippets": "Known or suspected ... HIV",
                    "criterion": "HIV infection",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "active or suspected"
                        }
                    ]
                },
                {
                    "exact_snippets": "Known or suspected ... hepatitis B",
                    "criterion": "hepatitis B infection",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "active or suspected"
                        }
                    ]
                },
                {
                    "exact_snippets": "Known or suspected ... hepatitis C infection",
                    "criterion": "hepatitis C infection",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": "active or suspected"
                        }
                    ]
                }
            ]
        }
    ],
    "failed_miscellaneous": []
}